|
1
|
Smith RA, Manassaram-Baptiste D, Brooks D,
Doroshenk M, Fedewa S, Saslow D, Brawley OW and Wender R: Cancer
screening in the United States, 2015: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 65:30–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang M, He Y, Shi L and Shi C:
Multivariate analysis by Cox proportional hazard model on prognosis
of patient with epithelial ovarian cancer. Eur J Gynaecol Oncol.
32:171–177. 2011.PubMed/NCBI
|
|
4
|
American College of Obstetricians and
Gynecologists Committee on Gynecologic Practice: Committee opinion
no. 477: The role of the obstetrician-gynecologist in the early
detection of epithelial ovarian cancer. Obstet Gynecol.
117:742–746. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sueblinvong T and Carney ME: Current
understanding of risk factors for ovarian cancer. Curr Treat
Options Oncol. 10:67–81. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng L, Song A, Ruan Y, Chen L, Liu D, Li
X, Guo H, Han J, Li Y, Tian X, et al: Genetic polymorphisms in
AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer
susceptibility among Chinese Han women. Cancer Epidemiol.
37:639–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mostowska A, Pawlik P, Sajdak S, Markowska
J, Pawałowska M, Lianeri M and Jagodzinski PP: An analysis of
polymorphisms within the Wnt signaling pathway in relation to
ovarian cancer risk in a Polish population. Mol Diagn Ther.
18:85–91. 2014. View Article : Google Scholar :
|
|
8
|
Brown EM, Gamba G, Riccardi D, Lombardi M,
Butters R, Kifor O, Sun A, Hediger MA, Lytton J and Hebert SC:
Cloning and characterization of an extracellular Ca(2+)-sensing
receptor from bovine parathyroid. Nature. 366:575–580. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vezzoli G, Terranegra A, Arcidiacono T,
Gambaro G, Milanesi L, Mosca E and Soldati L; GENIAL network
(Genetics and Environment in Nephrolithiasis Italian Alliance):
Calcium kidney stones are associated with a haplotype of the
calcium-sensing receptor gene regulatory region. Nephrol Dial
Transplant. 25:2245–2252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pearce SH and Thakker RV: The
calcium-sensing receptor: Insights into extracellular calcium
homeostasis in health and disease. J Endocrinol. 154:371–378. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brown EM and Hebert SC:
Calcium-receptor-regulated parathyroid and renal function. Bone.
20:303–309. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tu CL, Oda Y, Komuves L and Bikle DD: The
role of the calcium-sensing receptor in epidermal differentiation.
Cell Calcium. 35:265–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hendy GN, D'Souza-Li L, Yang B, Canaff L
and Cole DE: Mutations of the calcium-sensing receptor (CASR) in
familial hypocalciuric hypercalcemia, neonatal severe
hyperparathyroidism, and autosomal dominant hypocalcemia. Hum
Mutat. 16:281–296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rodland KD: The role of the
calcium-sensing receptor in cancer. Cell Calcium. 35:291–295. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jorde R, Schirmer H, Njølstad I, Løchen
ML, Bøgeberg Mathiesen E, Kamycheva E, Figenschau Y and Grimnes G:
Serum calcium and the calcium-sensing receptor polymorphism
rs17251221 in relation to coronary heart disease, type 2 diabetes,
cancer and mortality: The Tromsø Study. Eur J Epidemiol.
28:569–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Seaghdha CM, Yang Q, Glazer NL, Leak TS,
Dehghan A, Smith AV, Kao WH, Lohman K, Hwang SJ, Johnson AD, et al
GEFOS Consortium: Common variants in the calcium-sensing receptor
gene are associated with total serum calcium levels. Hum Mol Genet.
19:4296–4303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chou YH, Woon PY, Chen WC, Hsu YW, Chang
JM, Hwang DY, Chiu YC, Kuo HC, Chang WP, Hou MF, et al: A genetic
polymorphism (rs17251221) in the calcium-sensing receptor gene
(CASR) is associated with stone multiplicity in calcium
nephrolithiasis. PLoS One. 6:e252272011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Q, Zhao Y, Wang Y and Wei M: A
genetic variant (rs17251221) in the calcium-sensing receptor
relates to hepatocellular carcinoma susceptibility and clinical
outcome treated by transcatheter hepatic arterial chemoembolization
(TACE) therapy. Med Oncol. 31:2672014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Kong X, Jiang L, Ma T, Yan S, Yuan C
and Yang Q: A genetic polymorphism (rs17251221) in the
calcium-sensing receptor is associated with breast cancer
susceptibility and prognosis. Cell Physiol Biochem. 33:165–172.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Zhang N, Li X, Moran MS, Yuan C,
Yan S, Jiang L, Ma T, Haffty BG and Yang Q: Identification of novel
variants of metadherin in breast cancer. PLoS One. 6:e175822011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang N, Li X, Tao K, Jiang L, Ma T, Yan
S, Yuan C, Moran MS, Liang F, Haffty BG, et al: BCL-2 (−938C >
A) polymorphism is associated with breast cancer susceptibility.
BMC Med Genet. 12:482011. View Article : Google Scholar
|
|
22
|
Rodriguez S, Gaunt TR and Day IN:
Hardy-Weinberg equilibrium testing of biological ascertainment for
Mendelian randomization studies. Am J Epidemiol. 169:505–514. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng QH, Xu E, Hildebrandt MA, Liang D, Lu
K, Ye Y, Wagar EA and Wu X: Genetic variants in the fibroblast
growth factor pathway as potential markers of ovarian cancer risk,
therapeutic response, and clinical outcome. Clin Chem. 60:222–232.
2014. View Article : Google Scholar
|
|
24
|
Johnson CC, Kessel B, Riley TL, Ragard LR,
Williams CR, Xu JL and Buys SS; Prostate, Lung Colorectal and
Ovarian Cancer Project Team: The epidemiology of CA-125 in women
without evidence of ovarian cancer in the Prostate, Lung,
Colorectal and Ovarian Cancer (PLCO) Screening Trial. Gynecol
Oncol. 110:383–389. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duffy MJ, Bonfrer JM, Kulpa J, Rustin GJ,
Soletormos G, Torre GC, Tuxen MK and Zwirner M: CA125 in ovarian
cancer: European Group on Tumor Markers guidelines for clinical
use. Int J Gynecol Cancer. 15:679–691. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aggarwal A, Prinz-Wohlgenannt M, Tennakoon
S, Höbaus J, Boudot C, Mentaverri R, Brown EM, Baumgartner-Parzer S
and Kállay E: Calcium-sensing receptor: A promising target for
prevention of colorectal cancer. Biochim Biophys Acta. Feb
18–2015.Epub ahead of print. View Article : Google Scholar
|
|
27
|
Liu G, Hu X and Chakrabarty S: Calcium
sensing receptor down-regulates malignant cell behavior and
promotes chemosensitivity in human breast cancer cells. Cell
Calcium. 45:216–225. 2009. View Article : Google Scholar
|
